The role of serology for COVID-19 control : Population, kinetics and test performance do matter
| Errataetall: |
CommentIn: J Infect. 2020 Dec;81(6):e28-e30. - PMID 32739486 |
|---|---|
| Media Type: |
Electronic Article |
| Year of Publication: |
2020 |
|---|
| Contained In: |
The Journal of infection - Vol. 81, No. 2 (2020), p. e91-e92 |
|---|
| Language: |
English |
|---|
| Contributors: |
Tré-Hardy, Marie |
|---|
| Links: |
|---|
| Notes: |
Date Completed 13.08.2020 Date Revised 26.01.2021 published: Print-Electronic CommentIn: J Infect. 2020 Dec;81(6):e28-e30. - PMID 32739486 Citation Status MEDLINE Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine |
|---|
| Physical Description: |
Online-Ressource |
|---|
| doi: |
10.1016/j.jinf.2020.05.019 |
|---|---|
| PMID: |
32417311 |
| PPN (Catalogue-ID): |
NLM310869358 |
|---|
| LEADER | 02344nma a2200625 c 4500 | ||
|---|---|---|---|
| 001 | NLM310869358 | ||
| 003 | DE-601 | ||
| 005 | 20210126213551.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200518s2020 000 0 eng d | ||
| 024 | 7 | |a 10.1016/j.jinf.2020.05.019 |2 doi | |
| 028 | 5 | 2 | |a pubmed21n1123.xml |
| 035 | |a S0163-4453(20)30297-8 | ||
| 035 | |a (DE-599)NLM32417311 | ||
| 040 | |b ger |c GBVCP | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Tré-Hardy, Marie | |
| 245 | 1 | 4 | |a The role of serology for COVID-19 control |h Elektronische Ressource |b Population, kinetics and test performance do matter |
| 300 | |a Online-Ressource | ||
| 500 | |a Date Completed 13.08.2020 | ||
| 500 | |a Date Revised 26.01.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: J Infect. 2020 Dec;81(6):e28-e30. - PMID 32739486 | ||
| 500 | |a Citation Status MEDLINE | ||
| 500 | |a Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine | ||
| 611 | 2 | 7 | |a Letter |2 gnd |
| 653 | 2 | |a Antibodies, Viral |6 D000914 |a *blood |6 Q000097 | |
| 653 | 2 | |a Betacoronavirus |6 D000073640 |a immunology |6 Q000276 | |
| 653 | 2 | |a COVID-19 |6 D000086382 | |
| 653 | 2 | |a Coronavirus Infections |6 D018352 |a *diagnosis |6 Q000175 |a *immunology |6 Q000276 |a prevention & control |6 Q000517 | |
| 653 | 2 | |a False Negative Reactions |6 D005188 | |
| 653 | 2 | |a Humans |6 D006801 | |
| 653 | 2 | |a Kinetics |6 D007700 | |
| 653 | 2 | |a Pandemics |6 D058873 |a prevention & control |6 Q000517 | |
| 653 | 2 | |a Pneumonia, Viral |6 D011024 |a *diagnosis |6 Q000175 |a *immunology |6 Q000276 |a prevention & control |6 Q000517 | |
| 653 | 2 | |a SARS-CoV-2 |6 D000086402 | |
| 653 | 2 | |a Sensitivity and Specificity |6 D012680 | |
| 653 | 2 | |a *Serologic Tests |6 D012698 | |
| 653 | 2 | |a Time Factors |6 D013997 | |
| 655 | 7 | |a Antibodies, Viral |2 gnd | |
| 689 | 0 | 0 | |A f |a Letter |
| 689 | 0 | |5 DE-601 | |
| 689 | 2 | 0 | |a Antibodies, Viral |
| 689 | 2 | |5 DE-601 | |
| 700 | 1 | |a Blairon, Laurent | |
| 700 | 1 | |a Wilmet, Alain | |
| 700 | 1 | |a Beukinga, Ingrid | |
| 700 | 1 | |a Malonne, Hugues | |
| 700 | 1 | |a Dogné, Jean-Michel | |
| 700 | 1 | |a Douxfils, Jonathan | |
| 773 | 0 | 8 | |i in |t The Journal of infection |g Vol. 81, No. 2 (2020), p. e91-e92 |q 81:2<e91-e92 |w (DE-601)NLM012791911 |x 1532-2742 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1016/j.jinf.2020.05.019 |3 Volltext |
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 81 |j 2020 |e 2 |b 01 |c 08 |h e91-e92 | ||